---
title: "Liminatus Pharma Surges 13% in Regular Trading"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291579983.md"
description: "Liminatus Pharma jumped 13% during regular trading amid healthcare sector volatility."
datetime: "2026-07-02T19:01:16.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291579983.md)
  - [en](https://longbridge.com/en/news/291579983.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291579983.md)
generator: "portal-rs"
---

# Liminatus Pharma Surges 13% in Regular Trading

Liminatus Pharma(LIMN.US) 盘中涨**13.41%**，现报**0.1302 美元**。该股当日波动剧烈，此前在常规交易中曾一度飙升 50% 至 0.1726 美元，早盘涨幅也曾达 40.9%。消息面上，医疗保健板块周四盘中多只个股出现大幅波动，Liminatus Pharma 作为板块内活跃个股跟随波动。

### Related Stocks

- [LIMN.US](https://longbridge.com/en/quote/LIMN.US.md)

## Related News & Research

- [Liminatus Pharma discloses Ewon Comfortech initial beneficial ownership of 5.5 million shares](https://longbridge.com/en/news/291844263.md)
- [Liminatus Pharma annual meeting draws 48.31% of shares represented](https://longbridge.com/en/news/294876806.md)
- [Liminatus Pharma Q2 FY26 net loss widens to $1.41 million; operating loss widens 23% to $1.38 million](https://longbridge.com/en/news/295975537.md)
- [Liminatus Pharma Announces Proposed Merger with InnocsAI to Expand Oncology Cell Therapy Pipeline | LIMN Stock News](https://longbridge.com/en/news/287218720.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**